Sep 16, 2024 Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
Aug 27, 2024 Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
Aug 14, 2024 Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
Aug 12, 2024 Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
Aug 6, 2024 Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
Jun 27, 2024 Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Jun 21, 2024 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024